INVO Fertility, Inc. IVF

Company Overview

INVO Fertility, Inc. is a publicly traded fertility-focused healthcare company operating in the assisted reproductive technology (ART) and women’s health services industries. The company is best known for developing and commercializing the INVOcell® intravaginal culture system and for operating fertility clinics that provide infertility treatment services. Its primary revenue drivers include fertility treatment services delivered through owned and affiliated clinics, as well as limited product-related revenue tied to its proprietary fertility technology.

The company is positioned around expanding access to infertility care by offering lower-cost alternatives to traditional in vitro fertilization (IVF). INVO Fertility was founded to commercialize INVOcell®, a device that received U.S. FDA clearance and is designed to enable embryo incubation within the vaginal cavity. Over time, the company evolved from a product-centric model toward a clinic ownership and services model, reflecting a strategic shift to recurring healthcare service revenue and direct patient engagement.